Funding Information
The study funder is The Starship Foundation A +8211 (Auckland, New Zealand). The funder and the isCGM manufacturer had no roles or responsibilities in the study design, conduct, data analysis and interpretation, or article writing. Intervention supplies and blinded glucose sensors were purchased commercially from the isCGM manufacturer. C.A.J. is the recipient of a New Zealand Health Research Council (HRC) clinical practitioner research fellowship 20/026.